Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting

Completed

• Conditions: Gastrointestinal Stromal Tumors

• Registration Number: NCT00877045
• Lead Sponsor: SCRI Development Innovations, LLC

Brief Summary

This is a retrospective medical record abstraction to evaluate the patterns of care for Gastrointestinal stromal tumors (GIST) in the community setting. Patient demographics and characteristics along with the treatments received will be described. Investigators will establish the percentage of patients who undergo surgery, the percentage of patients who are treated with kinase inhibitors as well as in what setting (adjuvant or metastatic) as well as the duration of therapy. Physician information will also be collected to assess for differences in treatment based on physician or geographical differences.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-01
• Primary Completion: 2009-01
• Study Completion: 2009-02
• Study First Submitted: 2009-04-03
• Study First Submitted QC: 2009-04-06
• Study First Posted: 2009-04-07
• Status Verified: 2010-08
• Last Update Submitted: 2010-08-03
• Last Update Posted: 2010-08-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Patients diagnosed with GIST based on ICD-9 code from January 2005 to present will be eligible. This will include current active patients as well as patients who have expired and have medical chart available.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (5)

Georgia Cancer Specialists; 🇺🇸 Atlanta, Georgia, United States

Virginia Cancer Institute; 🇺🇸 Richmond, Virginia, United States

Florida Cancer Specialists; 🇺🇸 Fort Myers, Florida, United States

Chattanooga Oncology Hematology Associates; 🇺🇸 Chattanooga, Tennessee, United States

Tennessee Oncology, PLLC; 🇺🇸 Nashville, Tennessee, United States